Abstract: One embodiment of the present invention provides a system for performing secure multiparty cloud computation. During operation, the system receives multiple encrypted datasets from multiple clients. An encrypted dataset associated with a client is encrypted from a corresponding plaintext dataset using a unique, client-specific encryption key. The system re-encrypts the multiple encrypted datasets to a target format, evaluates a function based on the re-encrypted multiple datasets to produce an evaluation outcome, and sends the evaluation outcome to the multiple clients, which are configured to cooperatively decrypt the evaluation outcome to obtain a plaintext evaluation outcome.

Abstract: A networking system comprising a virtual group controller in an information centric network configured to enable mobility and security for a plurality of users groups of the information centric network, a plurality of user groups coupled to the virtual group controller and associated with the users, a plurality of agents that are each associated with one of the user groups, and a database for trusted service profile coupled to the virtual group controller, wherein the virtual group controller is configured to interact with the agents to enable mobility for the user groups using a server-less domain-based naming scheme.

Abstract: The present invention discloses compounds of Formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: The present invention relates to novel cyclosporine analogs having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analog compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.

Abstract: The present invention discloses compounds of formula Ia or Ib or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: The present invention relates to cyclosporin analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporin analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.

Abstract: A picture of a web page is a two-dimensional code picture and is determined when the picture is triggered. A user is prompted to determine whether to identify the two-dimensional code picture when the picture of the web page is the two-dimensional code picture. The two-dimensional code picture is parsed after receiving an instruction of identifying the two-dimensional code picture from the user. Two-dimensional code information is obtained, and processing is performed according to the two-dimensional code information.

Abstract: A method for routing content, comprising receiving an interest packet from a first face, wherein the interest packet comprises a content name field populated with a first content name, a destination field, and a broadcast flag field set to broadcast, wherein the broadcast field indicates whether the first face has previously received a request having the first content name, and receiving a data packet from a second face, wherein the data packet comprises a content name field populated with a second content name, a source field populated with the identity of a source of data associated with the second content name, and a data field populated with the data associated with the second content name.

Abstract: The disclosure discloses a method and device for controlling a composite scanning device, and a composite scanning system. The composite scanning system includes: a composite scanning device and a host which includes: an application module configured for performing a first capability setting on the composite scanning device, obtaining the scanned image data from the composite scanning device after the first capability setting, and processing the scanned image data in a first TWAIN session state; and a configuration module configured for performing a second capability setting on the composite scanning device according to the processing result of the application module in the first TWAIN session state. By the disclosure, the efficiency of capability setting in the composite scanning system which is compatible with TWAIN protocol can be improved.

Abstract: The present invention relates to 2?-allene-substituted nucleoside derivatives of the general formula (I): As well as pharmaceutical compositions comprising such compounds and methods to treat or prevent an HIV infection, HBV infection, HCV infection or abnormal cellular proliferation, comprising administering said compounds or compositions. In addition, the present invention includes processes for the preparation of such compounds, and the related ?-D and ?-L-nucleoside derivatives.

Abstract: A framework for a screen content sharing system with generalized screen descriptions is described. In one approach, a screen content update message is sent from a client device to a control plane where the client device wishes to share its screen content with a remote device. The remote device sends a message indicating an interest in receiving said update. The control plane subsequently retrieves a detailed description from the client device. Based on the computational context of the remote device, the detailed description may be trimmed to a more compatible format. In some embodiments, the detailed description is sent to the remote device and includes a screen description and a content description. The content of the shared screen is described and the content is subsequently retrieved from a service router. A shared screen content is assembled based on the screen description and the content retrieved from the service router.

Abstract: The present invention relates to novel cyclosporine analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.

Abstract: The present invention discloses compounds of formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: System and method for specifying and implementing programs. A graphical program is created in a graphical specification and constraint language that allows specification of a model of computation and explicit declaration of constraints in response to user input. The graphical program includes a specified model of computation, a plurality of interconnected functional blocks that visually indicate functionality of the graphical program in accordance with the specified model of computation, and specifications or constraints for the graphical program or at least one of the functional blocks in the graphical program. The specified model of computation and specifications or constraints are useable to analyze the graphical program or generate a program or simulation.

Abstract: The present invention relates generally to an improved process for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives which are useful intermediates in the synthesis of biologically active molecules, especially in the synthesis of hepatits C virus NS5A inhibitors.

Abstract: A networking system comprising a virtual group controller in an information centric network configured to enable mobility and security for a plurality of users groups of the information centric network, a plurality of user groups coupled to the virtual group controller and associated with the users, a plurality of agents that are each associated with one of the user groups, and a database for trusted service profile coupled to the virtual group controller, wherein the virtual group controller is configured to interact with the agents to enable mobility for the user groups using a server-less domain-based naming scheme.

Abstract: The present invention relates to processes and intermediates for the preparation of novel benzimidazole derivatives, especially in the synthesis of hepatitis C virus NS5A inhibitors.

Abstract: The present invention relates to novel cyclosporine analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.

Abstract: A network element (NE) comprising a memory configured to store a digest log for a conference, a receiver coupled to the memory and configured to receive a first message from a first of a plurality of service proxies of the conference, wherein the first message comprises a signature profile of a first of a plurality of participants of the conference associated with the first service proxy, a processor coupled to the receiver and the memory and configured to track a state of the conference by updating the digest log according to the first message, and a transmitter coupled to the processor and configured to send a plurality of second messages to indicate the digest log update to the service proxies without a transmission request from the service proxies.

Abstract: A network element (NE) comprising a memory configured to store a digest log for a conference, a receiver configured to receive a first message from a first of a plurality of participants associated with the NE, wherein the first message comprises a signature profile of the first participant, a processor coupled to the receiver and the memory and configured to track a state of the conference by performing a first update of the digest log according to the first message, and a transmitter coupled to the processor and configured to send a second message to a first of a plurality of service proxies that serve the conference, wherein the second messages indicate the updated digest log.